You are here

CBC Group

UAE’s Mubadala acquires full ownership of UCB Pharma’s China business with CBC Group

UAE’s Mubadala acquires full ownership of UCB Pharma’s China business with CBC Group

  • Value of transaction is expected to close in fourth quarter of 2024
  • Deal includes UCB’s neurology and allergy portfolios
By MIGUEL HADCHITY  ·

Opinion

Yossi Mekelberg
Netanyahu even more dangerous as corruption trial nears
Author
Hafed Al-Ghwell
How the West prospers as the rest drown
Author
Arnab Neil Sengupta
Trillion-dollar decarbonization estimates demand a global reality check
Author
Jean Pisani-Ferry and Simone Tagliapietra and Laurence Tubiana
The EU needs a strong clean industrial deal
Author
Dr Abdel Aziz Aluwaisheg
US veto confirms its responsibility for Israel’s crimes in Gaza
Author
More in Opinion

Latest updates

Ukraine needs better air defenses, Zelensky says after Russian drone attack
Ukraine needs better air defenses, Zelensky says after Russian drone attack
Saudi Arabia forms new committee to spur private sector role in petrochemicals
Saudi Arabia forms new committee to spur private sector role in petrochemicals
Fans praise co-star as May Calamawy’s role is cut from ‘Gladiator II’
Fans praise co-star as May Calamawy’s role is cut from ‘Gladiator II’
Saudi Arabia’s non-oil exports surge 16.8% in Q3: GASTAT 
Saudi Arabia’s non-oil exports surge 16.8% in Q3: GASTAT 
Verstappen wins fourth consecutive Formula One world title
Verstappen wins fourth consecutive Formula One world title

Recommended

Middle-East
How should Arab Americans deal with Trump administration?
How should Arab Americans deal with Trump administration?
World
How COP29 outcome may impact countries most affected by climate change
How COP29 outcome may impact countries most affected by climate change
Media
An AI-powered tool aims to combat fake news in the Arab world and beyond
An AI-powered tool aims to combat fake news in the Arab world and beyond

Search form

Print Edition
Read pdf version Subscribe now
© 2024 SAUDI RESEARCH & PUBLISHING COMPANY, All Rights Reserved And subject to Terms of Use Agreement.